Radiobiology Research Scientist – Preclinical Cancer Therapies

Radiobiology Research Scientist – Preclinical Cancer Therapies

Full-Time 50000 - 70000 £ / year (est.) No working from home possible
Bicycle Therapeutics

At a Glance

  • Tasks: Conduct in vitro and in vivo studies on Bicycle® Radio-Conjugates (BRCs™) for cancer therapies.
  • Company: Bicycle Therapeutics is located in Greater London and focuses on innovative cancer therapies.
  • Benefits: This hybrid role offers flexibility with attendance at both London and Cambridge offices.
  • Other info: The position supports the preclinical development of advanced cancer treatments.
  • Why this job: Join a pioneering team developing next-generation cancer therapies in a dynamic environment.
  • Qualifications: Candidates must have a strong background in radiobiology or cancer biology and relevant hands-on experience.

The predicted salary is between 50000 - 70000 £ per year.

Bicycle Therapeutics, located in Greater London, is seeking a skilled radiobiologist to support the preclinical development of Bicycle® Radio-Conjugates (BRCs™). The role involves conducting in vitro and in vivo studies to understand the efficacy and mechanisms behind next-generation cancer therapies.

This hybrid position requires attendance at the London office and occasional visits to the Cambridge office. Candidates should possess a strong educational background in radiobiology or cancer biology and hands-on experience with relevant techniques.

Radiobiology Research Scientist – Preclinical Cancer Therapies employer: Bicycle Therapeutics

Bicycle Therapeutics, based in Greater London, is at the forefront of cancer therapy innovation. Employees enjoy a hybrid work model, balancing office time in London and Cambridge. The team is dedicated to developing cutting-edge solutions for cancer treatment.

Bicycle Therapeutics

Contact Details:

Bicycle Therapeutics Recruitment Team

We think you need these skills to ace Radiobiology Research Scientist – Preclinical Cancer Therapies

Radiobiology
Cancer Biology
In Vitro Studies
In Vivo Studies
Efficacy Assessment
Mechanism Understanding
Preclinical Development